Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1CNS 1

Conditions

Spinal Cord Neoplasms 1Optic Nerve Glioma 1Medulloblastoma 1Familial ependymoma 1Dendritic Cell Sarcoma, Interdigitating 1Choroid Plexus Neoplasms 1Burkitt Lymphoma 1Astrocytoma 1

Interventions

Filgrastim 6Carboplatin 5Temozolomide 4Irinotecan 3Ifosfamide 3Granulocyte Colony-Stimulating Factor 3Etoposide 3Busulfan 3Topotecan 2Radiotherapy 2Peripheral Blood Stem Cell Transplantation 2Oxaliplatin 2Melphalan 2Magnetic Resonance Spectroscopy 2Cyproheptadine 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2trioctyl phosphine oxide 1sargramostim 1ixabepilone 1ispinesib 1imetelstat 1gallium Ga 68 dotatate 1fluorodopa F 18 1exatecan 1etoposide phosphate 1becatecarin 1alvocidib 1Vorinostat 1Vincristine 1Verteporfin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Optic Nerve Glioma × CK0238273 × Sarcoma × Clear all
NCT00363272 2013-01-16

Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma

National Cancer Institute (NCI)

Phase 1 Completed
30 enrolled
CNSLymphoidSarcoma

Familial ependymoma, Astrocytoma, Burkitt Lymphoma, Medulloblastoma, Spinal Cord Neoplasms, Choroid Plexus Neoplasms, Optic Nerve Glioma, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡